New malaria vaccine put to the test in Real-World trial
⭐️ VACCINE ⭐️
Not yet recruiting
This study tests a new malaria vaccine called SUM-101 in 24 adults in Tanzania who have had malaria before. Participants receive the vaccine or a placebo, then are exposed to a controlled malaria infection to see if the vaccine delays or prevents illness. The goal is to check saf…
Phase: PHASE1 • Sponsor: European Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC